Our data revealed that fusion HAC NVs had significantly higher affinity for PD‐L1 and CD47 on tumour cells than fusion WT NVs, which promoted the antitumour function of macrophages and T cells both in vitro and in vivo. The gene discussed is CD47; the disease is neoplasm.